Lumipulse® G pTau 217 Plasma

Lumipulse G pTau 217 Plasma is a test for in vitro diagnostic use with the automated LUMIPULSE G System for the quantitative measurement of Tau phosphorylated at threonine 217 (pTau 217) in human plasma (K2EDTA).

The Lumipulse G pTau 217 Plasma assay is intended to aid Healthcare providers to identify patients with amyloid pathology associated with Alzheimer’s disease.

The test is indicated for patients, aged 50 years and over, presenting with signs and symptoms of cognitive decline in a specialized care setting. The Lumipulse G pTau 217 Plasma assay is to be used as an adjunct to other diagnostic evaluations. This product is for professional use only.

Contact sales for information
Lumipulse® G pTau 217 Plasma Immunoreaction Cartridges

Product number 81544

3 x 14 Tests
Lumipulse® G pTau 217 Plasma Calibrators

Product number 81545

1 × 5 Concentrations
CE marked (IVDR)
Please contact your local Fujirebio representative for the availability of this product in your country.

Click here to navigate

  • Contact sales for information
  • Conditions of sale
  • Documentation
  • Insights
  • Product inquiry
  • Related products
  • Webinars

  • Conditions of sale

    To read the end user conditions of sale for this product please visit our Resource center.

  • Insights

  • Product inquiry

    CAPTCHA

    The provision of your data implies your consent to the processing of your data in our database and, depending on the option you choose, to receiving our monthly newsletter by e-mail.

    For more information on how we process your personal data and regarding the rights you have in this respect, we refer to our privacy policy, which we hold at your disposal HERE.

    If you no longer wish to receive our newsletter, you have the option to unsubscribe via the ‘unsubscribe’ tool at the bottom of the newsletter. If you want to have your data removed from our database, please contact us at: privacy@fujirebio.com.

    • Review past webinars

    Neurodegenerative diseases
    Replay available
    2026/03/03 - 10:00 AM EST / 16:00 CET

    Mapping Synaptic Loss: Where β‑synuclein Fits in the Biomarker Landscape

    Watch replay
    Neurodegenerative diseases
    Replay available
    2025/11/19 - 10:00 AM EST / 16:00 CET

    Unlocking the biology of dementia with Lewy bodies: Biomarker insights from DDC to synapses

    Watch replay
    Neurodegenerative diseases
    Replay available
    2021/11/18 - 18 November 2021

    Preparing for the future of plasma based Alzheimers disease diagnostics

    Watch replay

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.